ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of MGCD0103 (MG-0103) in Patients With Relapsed or Refractory Hodgkin's Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00358982
Recruitment Status : Terminated
First Posted : August 1, 2006
Last Update Posted : July 3, 2015
Sponsor:
Information provided by (Responsible Party):
Mirati Therapeutics Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : January 2009
  Actual Study Completion Date : January 2009
  Certification/Extension First Submitted : June 5, 2015